Ferrous sulfate + Ascorbic acid
Sorbifer Durules contains ferrous sulfate and ascorbic acid, which increases iron absorption.
Sorbifer Durules is used in:
Sorbifer Durules is used in adults and children over 12 years of age.
Before starting treatment with Sorbifer Durules, you should discuss it with your doctor or pharmacist.
Swallowing difficulties
In case of accidental inhalation of a tablet, you should contact your doctor as soon as possible.
This is because there is a risk of esophageal ulcers and stenosis if the tablet gets into the airways. This can result in persistent cough, hemoptysis, and (or) shortness of breath, even if the inhalation occurred several days to several months before the onset of these symptoms. Therefore, it should be assessed as soon as possible whether the tablet has damaged the airways.
The medicine may cause dark discoloration of the stool.
Sorbifer Durules should not be given to infants and children under 12 years of age. The medicine can cause poisoning in children.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should avoid taking the following medicines at the same time:
If Sorbifer Durules is taken at the same time as the following medicines, it may be necessary to change the dosage of these medicines. You should ensure the longest possible interval (at least 2 hours) between taking Sorbifer Durules and the following medicines:
Iron absorption may decrease when taken with tea, coffee, eggs, dairy products, wholemeal bread, cereals, and foods high in dietary fiber (plant fiber). You should ensure the longest possible interval between taking Sorbifer Durules and consuming these products.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
During pregnancy and breastfeeding, you should take the recommended doses (see section 3).
The medicine does not affect the ability to drive or use machines.
This medicine should always be taken strictly according to the doctor's instructions. In case of doubts, you should consult your doctor or pharmacist.
You should follow the dosage and treatment duration exactly.
The tablet should be swallowed whole, with water. It should not be sucked, chewed, or kept in the mouth.
The tablets should be taken before meals or during meals, depending on gastrointestinal tolerance.
The tablets should never be taken while lying down.
The recommended dose for adults and adolescents over 12 years of age is 1 tablet twice a day (morning and evening). If necessary, due to side effects, the dose can be reduced by half (1 tablet per day).
In iron deficiency anemia, if necessary, the dose can be increased to 3 or 4 tablets per day, given in two divided doses (morning and evening).
Sorbifer Durules should not be given to infants and children under 12 years of age.
The recommended dose during pregnancy is 1 tablet per day to prevent iron deficiency (prophylactically).
In case of iron deficiency, 1 tablet is usually taken twice a day (morning and evening).
The attending physician will determine the duration of treatment individually based on the patient's iron metabolism tests.
Sorbifer Durules should not be given to infants and children (under 12 years of age).
In case of accidental ingestion of too many tablets, you should contact your doctor or go to the nearest hospital immediately. Overdose is particularly dangerous for small children.
You should not take a double dose to make up for a missed dose.
You should not stop taking the medicine after iron deficiency has been replenished without consulting your doctor, but continue treatment according to your doctor's recommendations to replenish iron stores in the body (about 2 months). In case of symptomatic iron deficiency, treatment usually lasts 3 to 6 months.
In case of any further doubts about the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, Sorbifer Durules can cause side effects, although not everybody gets them.
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C. Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the carton after "expiry date (EXP)". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
The active substances of the medicine are: 100 mg of iron (II) in the form of iron (II) sulfate, dried, and 60 mg of ascorbic acid in one tablet .
The other ingredients are: povidone K 25, polyethylene powder, carbomer 934 P, magnesium stearate.
Coating: hypromellose, macrogol 6000, titanium dioxide (E 171), yellow iron oxide (E 172),
paraffin wax.
The tablets are ochre-colored, slightly convex on both sides, with the marking "Z" on one side.
A brown glass bottle with a PE cap with a locking mechanism that holds the tablets in the bottle, in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Egis Pharmaceuticals PLC
Keresztúri út 30-38
H-1106 Budapest
Hungary
Egis Pharmaceuticals PLC
Mátyás király u 65.
9900 Körmend
Hungary
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warsaw
Synoptis Industrial Sp. z o.o.
ul. Szosa Bydgoska 58
87-100 Toruń
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Marketing authorization number in Slovakia, the country of export: 12/0416/91-S
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.